Image_3_ELOVLs Predict Distinct Prognosis Value and Immunotherapy Efficacy In Patients With Hepatocellular Carcinoma.tif

Image_3_ELOVLs Predict Distinct Prognosis Value and Immunotherapy Efficacy In Patients With Hepatocellular Carcinoma.tif

Background<p>Hepatocellular carcinoma (HCC) is a primary malignancy of the liver with high prevalence worldwide and poor prognosis. It has been verified that elongation of very-long-chain fatty acids gene family (ELOVLs), a group of genes that responsible for elongation of saturated and polyun...

Full description

Saved in:
Bibliographic Details
Main Author: Yu Zhang (12946) (author)
Other Authors: Shujie Pang (13048869) (author), Bo Sun (177052) (author), Minbo Zhang (13048872) (author), Xiaoxiao Jiao (12105495) (author), Linying Lai (13048875) (author), Yiting Qian (2737831) (author), Ning Yang (114965) (author), Wenzhuo Yang (8300517) (author)
Published: 2022
Subjects:
Cancer
Cancer Cell Biology
Cancer Diagnosis
Cancer Genetics
Cancer Therapy (excl. Chemotherapy and Radiation Therapy)
Chemotherapy
Haematological Tumours
Molecular Targets
Radiation Therapy
Solid Tumours
Oncology and Carcinogenesis not elsewhere classified
hepatocellular carcinoma
ELOVLs
ELOVL1
prognosis
immunotherapy
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items